Not provided
Not provided
Not provided
Not provided
Not provided
Enough data for a publication, decision of Sponsor-PI
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Based on PET (18-PSS232) and MRI, glutamate release after N-acetylcystein challenge will be monitored in human brains.
Diagnostic trial with quantification of glutamate release in PET/MR.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 18F-PSS232 | Other | Subjects receive baseline PET with 18F-PSS232 and stimulation PET with 18F-PSS232 after medical challenge with N-acetylcystein |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 18F-PSS232 | Drug | Diagnostic PET Tracer |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Difference of Binding Potentials of 18F-PSS232 in different brain regions between Baseline PET and PET after medical challenge | for details, please see Innis: Journal of Cerebral Blood Flow & Metabolism (2007) 27, 1533-1539 | Baseline PET and PET after medical challenge will be scanned within 3 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Alfred Buck, Prof. Dr. | University of Zurich | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hopsital Zurich | Zurich | 8091 | Switzerland |
Not provided
| ID | Term |
|---|---|
| C000600167 | PSS232 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided